Skip to main content
    I

    Incyte Corporation (INCY)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $119.09
    -1.18 (-0.98%)

    Market Cap: $24.51B

    Last updated: Nov 17, 2026 at 4:35 PM ET

    Incyte Corporation (INCY) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Incyte (INCY) has a market cap of $24.51B and an enterprise value of $21.31B. Revenue grew 24.88% over the last 12 months from the 12 months before. Its trailing P/E of 45.5x is above its 5-year median of 24.9x.

    Total Valuation

    Enterprise value is 13.09% below the market cap, as cash exceeds debt.

    Market Cap$24.51B
    Enterprise Value$21.31B
    Latest price (Nov 17, 2026)$119.09

    Key Dates

    The next earnings report is expected on Feb 8, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 8, 2027 (expected)
    Last Earnings DateOct 29, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 1.43% in the quarter ended Sep 30, 2026 and grew 2.72% a year over 2 years.

    Shares Outstanding203.25M
    Shares Change (YoY)+3.87%
    Shares Change (QoQ)+1.43%
    Share Count Growth (2Y CAGR)+2.72%

    Valuation Ratios

    Sales and book value multiples are 4.0x and 4.3x. Its year-end P/E ranged from 14.5x to 185.7x from 2016 to 2025.

    P/E Ratio45.5x
    Forward P/E34.5x
    P/S Ratio4.0x
    Forward P/S4.0x
    P/B Ratio4.3x
    P/TBV Ratio4.5x
    P/FCF Ratio35.3x
    P/OCF Ratio32.9x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 28.3x EBITDA and 30.7x free cash flow.

    EV / Earnings52.8x
    EV / Sales3.5x
    EV / EBITDA28.3x
    EV / FCF30.7x

    Price Statistics

    The stock is up 14.34% over 52 weeks and trades 0.13% above its 50-day average.

    Beta (1Y)0.45
    52-Week Change+14.34%
    1-Month Change+5.16%
    3-Month Change-7.30%
    6-Month Change+24.57%
    5-Year Change+79.74%
    10-Year Change+38.43%
    Total Return (1Y)+14.34%
    Total Return (3Y CAGR)+29.94%
    Total Return (5Y CAGR)+12.84%
    Return vs SPY (1Y)+3.07%
    Max Drawdown (1Y)-18.33%
    Max Drawdown (3Y)-33.83%
    Sharpe Ratio (1Y)0.42
    Correlation with SPY (1Y)0.19
    50-Day Average$118.94
    200-Day Average$109.10
    52-Week Range$89.25 to $132.60
    RSI (14 Days)50.3
    Average Volume (20 Days)1.82M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 3.84x current liabilities, and total debt is 0.01x shareholder equity.

    Current Ratio3.84x
    Quick Ratio3.75x
    Debt / Equity0.01x
    Debt / EBITDA0.09x
    Debt / FCF0.10x
    Interest Coverage274.76x

    Returns and Efficiency

    Return on invested capital is 7.31% over the last 12 months, against a 5-year average of 22.85%.

    Return on Equity (ROE)7.15%
    Return on Assets (ROA)5.54%
    Return on Invested Capital (ROIC)7.31%
    ROE (5Y Average)14.06%
    ROA (5Y Average)10.59%
    ROIC (5Y Average)22.85%
    Asset Turnover0.88x
    Inventory Turnover3.56x
    Receivables Turnover5.09x
    Cash Conversion Cycle-28 days

    Taxes

    Income tax took 49.33% of pretax income over the last 12 months.

    Income Tax (TTM)$392.80M
    Effective Tax Rate49.33%

    Scores

    INCY has an Altman Z-Score of 10.68, in the safe zone above 2.99, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.

    Altman Z-Score10.68
    Altman Z ZoneSafe
    Piotroski F-Score7 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $6.01B over the last 12 months.

    Revenue$6.01B
    Revenue Growth (YoY)+24.88%
    Gross Profit$5.57B
    Operating Income$626.51M
    Pretax Income$796.21M
    Net Income$403.41M
    Reported EPS (TTM)$2.62

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 77.37% of the $7.29B in total assets.

    Cash and Equivalents$3.28B
    Total Debt$67.54M
    Net Cash$3.21B
    Net Cash Per Share$15.79
    Working Capital$4.08B
    Shareholder Equity$5.64B
    Book Value Per Share$27.76
    Tangible Book Value$5.41B
    Tangible Book Per Share$26.60
    Total Assets$7.29B
    Total Liabilities$1.64B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $60.12M of capital spending, operating cash flow left $684.87M of free cash flow.

    Operating Cash Flow$744.99M
    Capital Expenditures$60.12M
    Free Cash Flow$684.87M
    FCF Per Share$3.38
    Depreciation and Amortization$98.44M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 10.42%, against a 5-year average of 16.88%.

    Gross Margin92.69%
    Operating Margin10.42%
    Pretax Margin13.25%
    Net Margin6.71%
    FCF Margin11.39%
    Gross Margin (5Y Average)93.47%
    Operating Margin (5Y Average)16.88%
    Net Margin (5Y Average)16.75%

    Growth

    Revenue grew 14.84% a year over 3 years, and EPS 34.67% a year.

    Revenue Growth (3Y CAGR)+14.84%
    Revenue Growth (5Y CAGR)+14.03%
    EPS Growth (3Y CAGR)+34.67%
    FCF Growth (3Y CAGR)+14.94%
    Operating Income Growth (3Y CAGR)+37.76%
    Book Value Per Share Growth (2Y CAGR)+4.86%
    Tangible Book Per Share Growth (2Y CAGR)+5.16%

    Revenue and profit by year

    Dividends and Yields

    INCY does not pay a dividend. Its free cash flow yield is 2.83%.

    Earnings Yield2.20%
    FCF Yield2.83%
    Buyback Yield-1.88%
    Shareholder Yield-1.88%

    Stock Splits

    The last split was a 2-for-1 forward split on Sep 1, 2000.

    Last Split DateSep 1, 2000
    Split TypeForward split
    Split Ratio2:1

    Analyst Forecast

    Consensus estimates put revenue growth at 10.77% and EPS growth at 12.80% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+10.77%
    EPS Growth Forecast (2Y CAGR)+12.80%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About INCY

    What is INCY's market cap?

    Incyte has a market cap of $24.51B. Its enterprise value, which adds debt and subtracts cash, is $21.31B.

    What is INCY's P/E ratio?

    Incyte has a trailing P/E ratio of 45.5x and a forward P/E of 34.5x.

    How many shares of INCY are outstanding?

    Incyte has 203.25M shares outstanding. The count is up 3.87% from a year earlier.

    Does INCY pay a dividend?

    No. Incyte does not pay a dividend.

    How much debt does INCY have?

    Incyte has $67.54M of total debt and $3.28B of cash and equivalents, a net cash position of $3.21B.